Articles

Explore the potential of next-generation genome editing tools for driving the success of monoclonal antibodies for biotherapeutics.

Harnessing cell line engineering capabilities to enhance biotherapeutic products

Explore how Samsung Biologics’ DEVELOPICK™ can help mitigate development risk and identify candidates with the best potential for advancement to IND and beyond

DEVELOPICK™: High-throughput developability assessment to enable efficient formulation development

Ashland has launched Viatel™ ultrapure bioresorbable polymers (lactide / glycolide / caprolactone chemistries), a higher purity platform of controlled release polymers used in long acting injectables and implants (LAII). Ultrapure provides improved release consistency, extended-release durations and are better suited for sensitive drug compounds due to the less acidic micro-environment. 

Explore Ashland's Latest Innovation - Viatel™ Ultrapure Bioresorbable Polymers 

In this application note, Pfizer CentreOne examines key considerations for the development and manufacturing of your unique sterile injectable.

Supporting the unique needs of your sterile injectable with exact SI-ence (Dec 2023)

It analizes how to optimize a bio-decontamination process using an atomized hydrogen peroxide new cycle development method for use in pharmaceutical aseptic enclosures. 

Optimizing bio-decontamination in asseptic production

Through in-depth interviews with leading global manufacturers, the International Data Center (IDC) established the impact TrakSYS has on manufacturing operations.   

Discover The Business Value of TrakSYS™      

Advances in Protein A Chromatography

New Protein A resin for the elution at high pH

Vetting a CMO for sterile injectable fill finish means more than capacity and equipment. This white paper from Jubilant HollisterStier discusses the range of factors to consider when outsourcing manufacturing for aseptically filled and terminally sterilized products.

Selecting a CMO Partner for Sterile Injectable Manufacturing (Nov 2023)

In this eBook learn more on how to expedite the development pathway for early phase compounds, and how lipid based formulations provide innovative approach to enhance bioavailability for challenging molecules. It also presents how the lipid-based delivery provides a tool for highly potent, poorly soluble, and unstable APIs.

All Whitepapers